Through this diligent investigation, the FDA hopes to shed light on crucial questions by analyzing mountains of data. They want to illuminate the association between opioid use and overdose cases and identify any potential risks involved. Califf’s update gives us hope that this extensive review will unveil essential insights for healthcare providers, policymakers, and individuals affected by opioid misuse.
Come along on this exciting journey of discovery! Explore further to understand the complex web of prescription opioids and how it connects to the ongoing public health crisis.
A long-awaited review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway at the Food and Drug Administration, the agency’s commissioner said Tuesday. Dr. Robert Califf wrote in a blog entry that the FDA…